The in vitro inhibitory activity of spectinomycin was tested against various anaerobic bacteria. Different results were obtained with different media and with different initial pH's of the media. The highest minimum inhibitory concentrations for Bacteroides fragilis ('-128 ug/ml) were obtained with the use of Wilkins-Chalgren agar (pH 7.2) and Brucella blood agar (pH 7.0). Brucella blood agar at higher pH's (7.4 and 8.0) and Mueller-Hinton and Diagnostic Sensitivity Test agars produced lower minimum inhibitory concentrations (32 and 64 ,.g/ml). This same relationship between spectinomycin activity and pH of the medium was, in general, observed with these media and other anaerobes, including isolates of B. melaninogenicus, Fusobacterium, gram-positive cocci, Clostridium perfringens, and C. ramosum. The variable results observed in this study and in two others make it difficult to predict the clinical usefulness of spectinomycin in the treatment of anaerobic infections. It is probably most appropriate to be guided by results obtained with Wilkins-Chalgren agar and the method proposed as a reference to the National Committee for Clinical Laboratory Standards. These results indicate that spectinomycin is not a potent inhibitor of B. fragilis or other clinically significant anaerobes.
Spectinomycin is an aminocyclitol antimicrobial agent that is effective in the treatment of infections due to Neisseria gonorrhoeae (1) . Although the majority of strains ofEnterobacteriaceae (excluding Serratia and Proteus) are susceptible to spectinomycin (9) , it has not been used to treat infections caused by these organisms. Phillips and Warren (5) have reported that most of the 100 strains ofBacteroides fragilis that they examined were inhibited by 16 ,ug of spectinomycin per ml. Since this level is well below maximum achievable serum concentrations, they suggested that a therapeutic trial of spectinomycin against B. fragilis infections was justified. However, Ferguson and Smith (3) found spectinomycin to be much less active against B. fragilis. They concluded that the differing results were caused by the use of different media and methods of incubation. Because of these conflicting studies, we decided to determine the activity of spectinomycin against various anaerobes with the use ofseveral different media and by examining several parameters that might be causes of differing susceptibility results.
MATERIALS AND METHODS
Fifty-five clinical isolates were studied, including B. fragilis (25 isolates), B. melaninogenicus (6 isolates), Fusobacterium (6 isolates), anaerobic grampositive cocci (13 isolates), Clostridium perfringens (3 isolates), and C. ramosum (4 isolates). The minimum inhibitory concentration (MIC) was determined by an agar dilution method as described previously (7). Plates were incubated for 48 h in unvented GasPak These data suggest that for most anaerobes, and in particular for B. fragilis, the initial pH of the medium is an important factor in influencing the ultimate MIC value of spectinomycin. Those media with low pH's (7.0 to 7.2) will give higher MIC values than those with high initial pH's (7.4 to 8.0) when each susceptibility study is performed with incubation under the same anaerobic conditions. pH measurements of each agar medium were obtained just before and after 48 h of incubation at 37°C in GasPak jars. Each of the single medium plates contained 128 ,ug of spectinomycin per ml. The average change during incubation was 0.08 pH unit, and in each case except one this represented an increase in pH. WCA showed a decrease of 0.05 pH unit during incubation. These results do not show a significant change in pH of the medium during GasPak incubation. DISCUSSION The results of this study indicate that spectinomycin activity against anaerobes will vary depending on the medium used and that an important reason for this variation is a differing initial pH of the medium. MICs of spectinomycin were highest with the use of BA at pH 7.0 and WCA at pH 7.2, presumably because spectinomycin is less active at lower pH values.
ACTIVITY OF SPECTINOMYCIN AGAINST ANAEROBES
This phenomenon has been demonstrated previously for aminoglycosides (6) and erythromycin and lincomycin (4). Our results are similar to those obtained by Ferguson and Smith (3) , who found that most oftheirB. fragilis isolates had MICs of spectinomycin '70 jig/ml. This resistance pattern was not found by Phillips and Warren (5), who reported that all 38 of the B. fragilis isolates that they studied were inhibited by 16 ,g of spectinomycin per ml. They did acknowledge that different media pH's and different inoculum sizes could affect the results, but only at extreme ranges. Using the same medium (DST) as Phillips and Warren used, we obtained higher spectinomycin MICs (mode of 64 versus 16 ug/ml). Both studies used the GasPak system, but our inoculum was higher (105 versus 103 organisms). Ferguson et al. (2) attributed the lower spectinomycin MICs of Phillips and Warren to low C02 concentrations in the GasPak system (0.5 to 2.7%), whereas they had used an evacuation-replacement anaerobic jar method, which produced 7.5% C02. This excess C02 would tend to lower the pH of the medium. However hibited by -64 gg/ml. Since reported peak levels of spectinomycin in blood after a 2.0-g intramuscular dose are approximately 100 ug/ml (8) , it does not appear likely that this agent would be effective in the treatment of anaerobic infections. However, having said this, we must recognize that prior studies with the proposed NCCLS method have not included aminocyclitols and that the pH of WCA (7.2) does not favor the activity of these agents. It is possible that results with this method are not good predictors of in vivo spectinomycin activity against anaerobes. This possibility must, in turn, be tempered with our observations that the pH's of infected body fluids (other than blood) are generally low (5.0 to 6.0). Aminocyclitols may not be optimally active in this environment. The controversy will be settled only when appropriate in vivo studies are carried out.
